Efficacy of Vaccination against HPV infections to Prevent Cervical Cancer in France: Present Assessment and Pathways to Improve Vaccination Policies.

Abstract : Background: Seventy percent of sexually active individuals will be infected with Human Papillomavirus (HPV) during their lifetime. These infections are incriminated for almost all cervical cancers. In France, 3,068 new cases of cervical cancer and 1,067 deaths from cervical cancer occurred in 2005. Two vaccines against HPV infections are currently available and vaccination policies aim to decrease the incidence of HPV infections and of cervical cancers. In France, vaccine coverage has been reported to be low. Methods: We developed a dynamic model for the heterosexual transmission of Human Papillomavirus types 16 and 18, which are covered by available vaccines. A deterministic model was used with stratification on gender, age and sexual behavior. Immunity obtained from vaccination was taken into account. The model was calibrated using French data of cervical cancer incidence. Results: In view of current vaccine coverage and screening, we expected a 32% and 83% reduction in the incidence of cervical cancers due to HPV 16/18, after 20 years and 50 years of vaccine introduction respectively. Vaccine coverage and screening rates were assumed to be constant. However, increasing vaccine coverage in women or vaccinating girls before 14 showed a better impact on cervical cancer incidence. On the other hand, performing vaccination in men improves the effect on cervical cancer incidence only moderately, compared to strategies in females only. Conclusion: While current vaccination policies may significantly decrease cervical cancer incidence, other supplementary strategies in females could be considered in order to improve vaccination efficacy
Type de document :
Article dans une revue
PLoS ONE, Public Library of Science, 2012, 7 (3), pp.e 32251. <10.1371/journal.pone.0032251>
Liste complète des métadonnées

https://hal.archives-ouvertes.fr/hal-00678652
Contributeur : Laureen Ribassin-Majed <>
Soumis le : mardi 13 mars 2012 - 15:08:32
Dernière modification le : jeudi 9 février 2017 - 15:19:50
Document(s) archivé(s) le : jeudi 14 juin 2012 - 17:59:40

Fichier

MAJED_Plosone_2012.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Citation

Laureen Ribassin-Majed, Rachid Lounes, Stéphan Clémençon. Efficacy of Vaccination against HPV infections to Prevent Cervical Cancer in France: Present Assessment and Pathways to Improve Vaccination Policies.. PLoS ONE, Public Library of Science, 2012, 7 (3), pp.e 32251. <10.1371/journal.pone.0032251>. <hal-00678652>

Partager

Métriques

Consultations de
la notice

229

Téléchargements du document

217